New PreGen-Plus(TM) Colon Cancer Assay Offered by LabCorp(R) Beginning Today

BURLINGTON, N.C., Aug. 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced that the PreGen- Plus(TM) colon cancer assay is nationally available for LabCorp's clients to order beginning today. PreGen-Plus(TM) is the proprietary DNA-based stool

Laboratory Corporation of America(R) Announces 2003 Second Quarter Results

Reports EPS of $0.60; Operating Cash Flow Increases 32 Percent to $123 Million; Combined Genomic and Esoteric Testing Revenues Increase 34 Percent BURLINGTON, N.C., July 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for

LabCorp and Patient Safety Institute Partner to Improve Access to Laboratory Test Results and Preserve Patient Privacy

Alliance Will Leverage Medicity Technology to Serve Patients in the State of Delaware PLANO, Texas and BURLINGTON, N.C., Jul 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- The Patient Safety Institute (PSI) a leader in patient information, safety and healthcare connectivity, and Laboratory

LabCorp(R) Names M. Keith Weikel, Ph.D. to Its Board of Directors

BURLINGTON, N.C., July 18 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that M. Keith Weikel, Ph.D. has been elected to its Board of Directors, effective July 16, 2003. Dr. Weikel, 65, is a Senior Executive Vice President and Chief

LabCorp and Atherotech to Offer VAP Cholesterol Test

BURLINGTON, N.C., Jul 7, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced that it has entered into a marketing and distribution relationship with Atherotech, a leading cardiodiagnostic company and specialty reference

Laboratory Corporation of America(R) Announces 2003 First Quarter Results

Reports Strong Operating Cash Flow of $135 Million; Combined Genomic and Esoteric Testing Revenues Increase 33 Percent BURLINGTON, N.C., Apr 28, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for the quarter

LabCorp's Chief Scientific Officer Scheduled to Present Company's Oncology Strategy at Wachovia Securities Cancer Diagnostics Conference

BURLINGTON, N.C., April 9 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Myla Lai-Goldman, M.D., LabCorp Executive Vice President, Chief Scientific Officer and Medical Director, is scheduled to present an overview of the

LabCorp(R) Scheduled to Present at the SunTrust Robinson Humphrey Annual Institutional Investors Conference

BURLINGTON, N.C., April 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs and licensing, is scheduled to speak at the SunTrust Robinson Humphrey Annual Institutional

LabCorp(R) Scheduled to Present at the Banc of America Securities Health Care Conference

BURLINGTON, N.C., Mar 25, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Banc of America Securities Health Care Conference in

LabCorp(R) Scheduled to Present at the SG Cowen 23rd Annual Health Care Conference

BURLINGTON, N.C., Mar 19, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs and licensing, is scheduled to speak at the SG COWEN 23RD Annual Health Care